RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Protein tyrosine kinase 7 (PTK7) and cancer-associated fibroblasts (CAFs) play important roles in cancer stemness, respectively. However, little is known about interaction between CAFs and PTK7 in cancers. In this study, we showed that PTK7 was significantly correlated with the Wnt/β-Catenin pathway and aggressive clinicopathologic features in human head and neck squamous cell carcinoma (HNSCC). Meanwhile, animal experiments showed that PTK7 enhanced chemoresistance and lung metastasis of HNSCC in vivo. In addition, co-immunoprecipitation (co-IP) assay demonstrated that POSTN secreted by CAFs was a potential upstream ligand of PTK7 which might act as a receptor. Further analysis revealed that POSTN promoted the cancer stem cell (CSC)-like phenotype via PTK7–Wnt/β-Catenin signaling, including the proliferation and invasion of HNSCC cells in vitro, as well as tumor initiation and progression in vivo. Collectively, our study proved that CAF-derived POSTN might promote cancer stemness via interacting with PTK7 in HNSCC, suggesting that the combination of POSTN and PTK7 might be a potential prognostic and diagnostic indicator and a promising therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Soulieres, D., Senzer, N. N., Vokes, E. E., Hidalgo, M., Agarwala, S. S., & Siu, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.075 · Cited by 807
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Yeo, W., Chan, S. L., Mo, F. K., Chu, C. M., Hui, J. W., Tong, J. H., Chan, A. W., Koh, J., Hui, E. P., Loong, H., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1334-6 · Cited by 125
Research works printed but not linked: 60
- Torre, L. A. et al. 1 Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87–108 (2015). · DOI · Paper page
- D’Cruz, A. K. et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N. Engl. J. Med. 373, 521–529 (2015). · doi:10.1056/nejmoa1506007
- Chen, D. et al. Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell 20, 621–634.e626 (2017). · DOI · Paper page
- Li, P. et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/beta-catenin. Oncogenesis 6, e322 (2017). · DOI
- Li, C. et al. CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer. Theranostics 7, 67–80 (2017). · DOI
- Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744–749 (2005). · DOI · Paper page
- Yan, M. et al. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Mol. Cell Proteomics 12, 3271–3284 (2013). · DOI
- Jung, P. et al. Isolation of human colon stem cells using surface expression of PTK7. Stem Cell Rep. 5, 979–987 (2015). · DOI · Paper page
- Liu, Q. et al. PTK7 regulates Id1 expression in CD44-high glioma cells. Neuro-Oncol. 17, 505–515 (2015). · doi:10.1093/neuonc/nou227
- Dong, Y. et al. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma. Pol. J. Pathol. 68, 49–54 (2017). · doi:10.5114/pjp.2017.67615
- Puppo, F. et al. Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin canonical signalling. EMBO Rep. 12, 43–49 (2011). · DOI
- Hayes, M. et al. ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in disease. Nat. Commun. 5, 4777 (2014). · DOI · Paper page
- Hayes, M., Naito, M., Daulat, A., Angers, S. & Ciruna, B. Ptk7 promotes non-canonical Wnt/PCP-mediated morphogenesis and inhibits Wnt/beta-catenin-dependent cell fate decisions during vertebrate development. Development 140, 1807–1818 (2013). · DOI
- Berger, H., Wodarz, A. & Borchers, A. PTK7 faces the Wnt in development and disease. Front. Cell Dev. Biol. 5, 31 (2017). · DOI · Paper page
- Bin-Nun, N. et al. PTK7 modulates Wnt signaling activity via LRP6. Development 141, 410–421 (2014). · DOI
- Xian, L. et al. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche. Nat. Commun. 8, 15008 (2017). · DOI
- Kim, J. H., Park, S. Y., Jun, Y., Kim, J. Y. & Nam, J. S. Roles of Wnt target genes in the journey of cancer stem cells. Int. J. Mol. Sci. 18, E1604 (2017). · DOI · Paper page
- Fu, L. et al. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/beta-catenin signalling pathway. Gut 60, 1635–1643 (2011). · DOI
- Xu, X. et al. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche. Oncotarget 7, 798–813 (2016). · DOI
- Oskarsson, T. & Massague, J. Extracellular matrix players in metastatic niches. EMBO J. 31, 254–256 (2012). · DOI
- Cui, D., Huang, Z., Liu, Y. & Ouyang, G. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression. Cell. Mol. Life Sci. 74, 4287–4291 (2017). · DOI
- Bao, S. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 5, 329–339 (2004). · DOI · Paper page
- Shi, Y., Ping, Y. F., Zhang, X. & Bian, X. W. Hostile takeover: glioma stem cells recruit TAMs to support tumor progression. Cell Stem Cell 16, 219–220 (2015). · DOI
- Zhang, R. et al. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Sci. Rep. 7, 2164 (2017). · DOI
- Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85–89 (2011). · DOI · Paper page
- Zhang, F. et al. Periostin: a downstream mediator of EphB4-induced osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Stem Cells Int. 2016, 7241829 (2016). · DOI
- Lv, J. et al. Involvement of periostin-sclerostin-Wnt/beta-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin. Biochem. Biophys. Res. Commun. 468, 587–593 (2015). · DOI
- Qin, X. et al. TGFbeta3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis. Sci. Rep. 6, 20587 (2016). · DOI · Paper page
- Lee, T. K. et al. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 9, 50–63 (2011). · DOI · Paper page
- Lin, C. et al. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma. Cancer Lett. 377, 1–10 (2016). · DOI
- Ma, H. et al. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma. Br. J. Cancer 118, 509–521 (2018). · DOI
- Yao, M. et al. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head. Neck 38(Suppl. 1), E1770–E1776 (2016).
- Morra, L. & Moch, H. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 459, 465–475 (2011). · DOI · Paper page
- Tian, B., Zhang, Y. & Zhang, J. Periostin is a new potential prognostic biomarker for glioma. Tumour Biol. 35, 5877–5883 (2014). · DOI
- Gross, A. M. & Orosco, R. K. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat. Genet. 46, 939–943 (2014). · DOI
- Chen, G., Yan, M., Li, R. R. & Chen, W. T. Sonic hedgehog signalling activation contributes to ALCAM over-expression and poor clinical outcome in patients with oral squamous cell carcinoma. Chin. J. Dent. Res. 21, 31–40 (2018).
- Wang, C., Liu, X. Q., Hou, J. S., Wang, J. N. & Huang, H. Z. Molecular mechanisms of chemoresistance in oral cancer. Chin. J. Dent. Res. 19, 25–33 (2016).
- Tian, X. et al. PTK7 overexpression in colorectal tumors: clinicopathological correlation and prognosis relevance. Oncol. Rep. 36, 1829–1836 (2016). · DOI
- Lin, Y. et al. PTK7 as a novel marker for favorable gastric cancer patient survival. J. Surg. Oncol. 106, 880–886 (2012). · doi:10.1002/jso.23154
- Gartner, S. et al. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement. PLoS ONE 9, e84472 (2014). · DOI
- Jin, J., Ryu, H. S., Lee, K. B. & Jang, J. J. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma. PLoS ONE 9, e90247 (2014). · DOI
- Golubkov, V. S. & Strongin, A. Y. Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells. Cell Commun. Signal. 12, 15 (2014). · doi:10.1186/1478-811x-12-15
- Chen, R. et al. A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma. Cancer Res. 74, 2892–2902 (2014). · DOI · Paper page
- Damelin, M. et al. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Sci. Transl. Med. 9, pii: eaag2611 (2017). · DOI · Paper page
- Katoh, M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int. J. Oncol. 51, 1357–1369 (2017). · DOI · Paper page
- Mittal, V. et al. The microenvironment of lung cancer and therapeutic implications. Adv. Exp. Med. Biol. 890, 75–110 (2016). · DOI
- Labernadie, A. et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat. Cell Biol. 19, 224–237 (2017). · DOI · Paper page
- Marsh, T., Pietras, K. & McAllister, S. S. Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070–1078 (2013). · DOI · Paper page
- Ostman, A. & Augsten, M. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr. Opin. Genet. Dev. 19, 67–73 (2009). · DOI · Paper page
- Zhang, F. et al. Periostin upregulates Wnt/beta-catenin signaling to promote the osteogenesis of CTLA4-modified human bone marrow-mesenchymal stem cells. Sci. Rep. 7, 41634 (2017). · DOI
- Bonnet, N., Conway, S. J. & Ferrari, S. L. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc. Natl. Acad. Sci. USA 109, 15048–15053 (2012). · DOI · Paper page
- Boras-Granic, K. & Wysolmerski, J. J. Wnt signaling in breast organogenesis. Organogenesis 4, 116–122 (2008). · DOI
- Ma, J., Lu, W., Chen, D., Xu, B. & Li, Y. Role of Wnt co-receptor LRP6 in triple negative breast cancer cell migration and invasion. J. Cell Biochem. 118, 2968–2976 (2017). · DOI
- Tammela, T. et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545, 355–359 (2017). · DOI · Paper page
- Yan, K. S. et al. Non-equivalence of Wnt and R-spondin ligands during Lgr5(+) intestinal stem-cell self-renewal. Nature 545, 238–242 (2017). · DOI · Paper page
- Janda, C. Y. et al. Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature 545, 234–237 (2017). · DOI · Paper page
- Ruan, K., Bao, S. & Ouyang, G. The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 66, 2219–2230 (2009). · DOI · Paper page
- Wu, X. et al. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol. Cancer 12, 151 (2013). · DOI
- Budwit-Novotny, D. A. et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 46, 5419–5425 (1986).
- Azim, H. A. Jr et al. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy. Breast Cancer Res. 17, 24 (2015). · DOI · Paper page
Cited by
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Fiori, M. E., Di Franco, S., Villanova, L., Bianca, P., Stassi, G., & De Maria, R. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0994-2 · Cited by 647
Yoshida, G. J. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01611-0 · Cited by 316
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
Pereira, B. A., Vennin, C., Papanicolaou, M., Chambers, C. R., Herrmann, D., Morton, J. P., Cox, T. R., & Timpson, P. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.09.010 · Cited by 314
Metadata
- Authors
- Yu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M.
- Venue
- Cell Death & Disease
- Published
- 2018-10-22
- Volume
- 9
- Issue
- 11
- Pages
- 1082-1082
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2896101912
- Cited by
- 121
- References
- 6
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2024-01-15)
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. https://app.cochat.ai/papers/10.1038/s41419-018-1116-6
- The paper
- Yu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M. (2018). RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. Cell Death & Disease. https://doi.org/10.1038/s41419-018-1116-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.